购物车
- 全部删除
- 您的购物车当前为空
DNMT1/HDAC-IN-1 (compound (R)-23a) 作为一种针对DNMT1/HDAC的双重抑制剂,具有良好的选择性,其对HDAC1的抑制常数(IC50)为0.05 μM。HDAC1为多个蛋白质复合物中的主要HDAC异构体,能与DNMT1交互作用,参与TSGs的转录沉默。此外,DNMT1/HDAC-IN-1能有效重塑肿瘤免疫微环境并诱导肿瘤退化,逆转癌症特异性的表观遗传异常。
DNMT1/HDAC-IN-1 (compound (R)-23a) 作为一种针对DNMT1/HDAC的双重抑制剂,具有良好的选择性,其对HDAC1的抑制常数(IC50)为0.05 μM。HDAC1为多个蛋白质复合物中的主要HDAC异构体,能与DNMT1交互作用,参与TSGs的转录沉默。此外,DNMT1/HDAC-IN-1能有效重塑肿瘤免疫微环境并诱导肿瘤退化,逆转癌症特异性的表观遗传异常。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | DNMT1/HDAC-IN-1 (compound (R)-23a), a poTenT dual inhibiTor TargeTing boTh DNMT1 and HDAC, exhibiTs impressive inhibiTory effecTs specifically on HDAC1 (HDAC1:IC50=0.05 μM), a major HDAC isoform ThaT inTeracTs wiTh DNMT1 across mulTiple proTein complexes involved in The TranscripTional silencing of TSGs. This compound has been shown To remodel The Tumor immune microenvironmenT and induce Tumor regression, effecTively reversing cancer-specific epigeneTic abnormaliTies. |
靶点活性 | HDAC1:0.05 μM |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容